Effects of Danshen tablets on pharmacokinetics of amlodipine in rats

References

• Adake P, Somashekar HS, Mohammed Rafeeq PK, Umar D, Basheer B, Baroudi K. 2015. Comparison of amlodipine with cilnidipine on antihypertensive efficacy and incidence of pedal edema in mild to moderate hypertensive individuals: a prospective study. J Adv Pharm Technol Res. 6:81–85.
   PubMed Web of Science ®Google Scholar
• Agrawal H, Aggarwal K, Littrell R, Velagapudi P, Turagam MK, Mittal M, Alpert MA. 2015. Pharmacological and non pharmacological strategies in the management of coronary artery disease and chronic kidney disease. Curr Cardiol Rev. 11:261–269.
   PubMed Web of Science ®Google Scholar
• Feldman L, Vinker S, Efrati S, Beberashvili I, Gorelik O, Wasser W, Shani M. 2016. Amlodipine treatment of hypertension associates with a decreased dementia risk. Clin Exp Hypertens. 38:545–549.
   PubMed Web of Science ®Google Scholar
• Glesby MJ, Aberg JA, Kendall MA, Fichtenbaum CJ, Hafner R, Hall S, Grosskopf N, Zolopa AR, Gerber JG. 2005. Pharmacokinetic interactions between indinavir plus ritonavir and calcium channel blockers. Clin Pharmacol Ther. 78:143–153.
   PubMed Web of Science ®Google Scholar
• Hsiao HL, Langenickel TH, Greeley M, Roberts J, Zhou W, Pal P, Rebello S, Rajman I, Sunkara G. 2015. Pharmacokinetic drug-drug interaction assessment between LCZ696, an angiotensin receptor neprilysin inhibitor, and hydrochlorothiazide, amlodipine, or carvedilol. Clin Pharmacol Drug Dev. 4:407–417.
   PubMed Web of Science ®Google Scholar
• Jia Y, Liu J, Xu J. 2018. Influence of grapefruit juice on pharmacokinetics of triptolide in rats grapefruit juice on the effects of triptolide. Xenobiotica. 48:407–411.
   PubMed Web of Science ®Google Scholar
• Khodadoustan S, Nasri Ashrafi I, Vanaja Satheesh K, Kumar C, Hs S, S C. 2017. Evaluation of the effect of time dependent dosing on pharmacokinetic and pharmacodynamics of amlodipine in normotensive and hypertensive human subjects. Clin Exp Hypertens. 39:520–526.
   PubMed Web of Science ®Google Scholar
• Lee CK, Choi JS, Choi DH. 2015. Effects of HMG-CoA reductase inhibitors on the pharmacokinetics of nifedipine in rats: possible role of P-gp and CYP3A4 inhibition by HMG-CoA reductase inhibitors. Pharmacol Rep. 67:44–51.
   PubMed Web of Science ®Google Scholar
• Lee JE, van Heeswijk R, Alves K, Smith F, Garg V. 2011. Effect of the hepatitis C virus protease inhibitor telaprevir on the pharmacokinetics of amlodipine and atorvastatin. Antimicrob Agents Chemother. 55:4569–4574.
   PubMed Web of Science ®Google Scholar
• Liu L, Geng G, Sun S, Li P, Li X. 2018. Effects of berberine on pharmacokinetics of amlodipine in rats and its potential mechanism. Lat Am J Pharm. 37:1354–1360.
   Web of Science ®Google Scholar
• Mannemala SS, Nagarajan JS. 2015. Development and validation of a HPLC-PDA bioanalytical method for the simultaneous estimation of aliskiren and amlodipine in human plasma. Biomed Chromatogr. 29:346–352.
   PubMed Web of Science ®Google Scholar
• Naito T, Kubono N, Ishida T, Deguchi S, Sugihara M, Itoh H, Kanayama N, Kawakami J. 2015. CYP3A activity based on plasma 4β-hydroxycholesterol during the early postpartum period has an effect on the plasma disposition of amlodipine. Drug Metab Pharmacokinet. 30:419–424.
   PubMed Web of Science ®Google Scholar
• Oh M, Park SE, Ghim JL, Choi YK, Shim EJ, Shin JG, Kim EY. 2017. Comparative pharmacokinetics of a fixed-dose combination vs. concomitant administration of telmisartan and S-amlodipine in healthy adult volunteers. Drug Design Devel Ther. 11:3543–3550.
   PubMed Web of Science ®Google Scholar
• Qi XY, Liang SC, Ge GB, Liu Y, Dong PP, Zhang JW, Wang AX, Hou J, Zhu LL, Yang L, et al. 2013. Inhibitory effects of sanguinarine on human liver cytochrome P450 enzymes. Food Chem Toxicol. 56:392–397.
   PubMed Web of Science ®Google Scholar
• Qin CZ, Ren X, Tan ZR, Chen Y, Yin JY, Yu J, Qu J, Zhou HH, Liu ZQ. 2014. A high-throughput inhibition screening of major human cytochrome P450 enzymes using an in vitro cocktail and liquid chromatography-tandem mass spectrometry. Biomed Chromatogr. 28:197–203.
   PubMed Web of Science ®Google Scholar
• Ryu SH, Kim JW, Kim YS, Lee SH, Cho YB, Lee HK, Kim YG, Jeong WS, Kim KB. 2014. Negligible pharmacokinetic interaction of red ginseng and antihypertensive agent amlodipine in Sprague–Dawley rats. J Toxicol Environ Health A. 77:1372–1383.
   PubMed Web of Science ®Google Scholar
• Shi M, Sun W, Sun G, Zhang J. 2016. Total monitoring of the constituents of Danshen tablet using micellar electrokinetic chromatography fingerprinting for antioxidant activity profiling. J Separat Sci. 39:1776–1784.
   PubMed Web of Science ®Google Scholar
• Wang R, Zhang H, Wang Y, Yu X, Yuan Y. 2016. Effects of salvianolic acid B and tanshinone IIA on the pharmacokinetics of losartan in rats by regulating the activities and expression of CYP3A4 and CYP2C9. J Ethnopharmacol. 180:87–96.
   PubMed Web of Science ®Google Scholar
• Wang S, Ouyang B, Aa J, Geng J, Fei F, Wang P, Wang J, Peng Y, Geng T, Li Y, et al. 2016. Pharmacokinetics and tissue distribution of ginkgolide A, ginkgolide B, and ginkgolide K after intravenous infusion of Ginkgo diterpene lactones in a rat model. J Pharm Biomed Anal. 126:109–116.
   PubMed Web of Science ®Google Scholar
• Yang SH, Choi JS, Choi DH. 2011. Effects of HMG-CoA reductase inhibitors on the pharmacokinetics of losartan and its main metabolite EXP-3174 in rats: possible role of CYP3A4 and P-gp inhibition by HMG-CoA reductase inhibitors. Pharmacology. 88:1–9.
   PubMed Web of Science ®Google Scholar
• Yao H, Huang X, Li S, Wu Y, Lin X, Shi P. 2017. Simultaneous determination of eight phenolic acids, five saponins and four tanshinones for quality control of compound preparations containing danshen-sanqi herb-pair by HPLC-DAD. Pharmacogn Mag. 13:64–75.
   PubMed Web of Science ®Google Scholar
• Yin QS, Chen L, Mi RH, Ai H, Yin JJ, Liu XJ, Wei XD. 2016. Efficacy and safety of danshen compound tablets in preventing thalidomide-associated thromboembolism in patients with multiple myeloma: a multicenter retrospective study. Med Sci Monit. 22:3835–3842.
   PubMed Web of Science ®Google Scholar
• Zhang C, Gao Z, Niu L, Chen X. 2018. Effects of triptolide on pharmacokinetics of amlodipine in rats by using LC-MS/MS. Pharm Biol. 56:132–137.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Xie P, Guo X, Kang W. 2016. Procoagulant substance and mechanism of Myristica fragrans. J Med Food. 19:1065–1073.
   PubMed Web of Science ®Google Scholar
• Zheng X, Liu T, Chen X, Chen X, Jiang J, Hu P. 2016. Investigation of a potential pharmacokinetic interaction between perindopril arginine and amlodipine when administered as a single perindopril/amlodipine fixed-dose combination tablet in healthy Chinese male volunteers. Int J Clin Pharmacol Ther. 54:43–51.
   PubMed Web of Science ®Google Scholar
• Zhu Y, Wang F, Li Q, Zhu M, Du A, Tang W, Chen W. 2014. Amlodipine metabolism in human liver microsomes and roles of CYP3A4/5 in the dihydropyridine dehydrogenation. Drug Metab Dispos. 42:245–249.
   PubMed Web of Science ®Google Scholar